Peripheral Nerve Injury: Clinical Trials

6 trials for Peripheral Nerve Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 withdrawn, 1 recruiting, 1 unknown. 6 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 2, Withdrawn 2, Recruiting 1, Unknown 1
Phase 24Withdrawn 2, Completed 1, Unknown 1

Follow Peripheral Nerve Injury: new trials by email Literature Review of Peripheral Nerve Injury trials Research Report on Peripheral Nerve Injury

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)
Autologous Human Schwann Cell - Peripheral Nerve Injury
Phase 1RecruitingW. Dalton Dietrich302023-05-042026-09-29
Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration
Polyethylene Glycol 3350, Normal Saline - Peripheral Nerve Injury, Nerve Injury
Phase 1 / Phase 2WithdrawnNova Scotia Health Authority2020-06-262024-01-05
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
Polyethylene glycol (PEG) - Peripheral Nerve Injury
Phase 1CompletedVanderbilt University Medical Center452019-09-192026-06-15
Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury
Neovasculgen - Peripheral Nerve Injury
Phase 1 / Phase 2UnknownArtgen Biotech452015-04-012015-02-02
Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus
Tacrolimus - Peripheral Nerve Injury
Phase 1 / Phase 2WithdrawnWashington University School of Medicine2010-08-012018-02-13
Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain
CAPNP, 50 ug/cm2 capsaicin patch, CAPNP, 100 ug/cm2 capsaicin patch, 0.075% capsaicin cream - Peripheral Nerve Injury, Postherpetic Neuralgia
Phase 1 / Phase 2CompletedSamyang Biopharmaceuticals Corporation602009-02-012017-05-01

Narrower conditions

Peripheral Nerve Injuries (6)  ·  Neuralgia, Postherpetic (1)  ·  Trauma, Nervous System (1)

Broader conditions

Nervous System Diseases (6)  ·  Neuromuscular Diseases (6)  ·  Peripheral Nervous System Diseases (6)  ·  Wounds and Injuries (6)  ·  Trauma, Nervous System (5)  ·  Neuralgia (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Polyethylene Glycols (1)  ·  Saline Solution (1)  ·  Tacrolimus (1)  ·  polyethylene glycol 3350 (1)

Sponsors

Artgen Biotech (1)  ·  Nova Scotia Health Authority (1)  ·  Samyang Biopharmaceuticals Corporation (1)  ·  Vanderbilt University Medical Center (1)  ·  W. Dalton Dietrich (1)  ·  Washington University School of Medicine (1)

Countries

United States (2)  ·  South Korea (1)

Top investigators

Thomas H Tung, MD (1)  ·  W. Dalton Dietrich, MD (1)  ·  Wesley Thayer, MD (1)

Results publications

PMID 28158151